Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
Nature Communications
|
February 26, 2022
Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategies
Valentina Cordo', Mariska T Meijer, Rico Hagelaar, et al.
Molecular Cancer Therapeutics
|
November 2, 2018
Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017
Joost C M Uitdehaag, Jeffrey J Kooijman, Jeroen A D M de Roos, et al.
Oncotarget
|
April 19, 2017
Stable aneuploid tumors cells are more sensitive to TTK inhibition than chromosomally unstable cell lines
Marion A A Libouban, Jeroen A D M de Roos, Joost C M Uitdehaag, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 5, 2009
Nonpeptidergic allosteric antagonists differentially bind to the CXCR2 chemokine receptor
Petra de Kruijf, Jane van Heteren, Herman D Lim, et al.
Journal of Molecular Biology
|
May 26, 2017
Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity
Joost C M Uitdehaag, Jos de Man, Nicole Willemsen-Seegers, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 5, 2005
Psychiatry in Europe
M Agius, R Zaman, S Singh, et al.
Molecular Cancer Therapeutics
|
September 3, 2016
Cell Panel Profiling Reveals Conserved Therapeutic Clusters and Differentiates the Mechanism of Action of Different PI3K/mTOR, Aurora Kinase and EZH2 Inhibitors
Joost C M Uitdehaag, Jeroen A D M de Roos, Martine B W Prinsen, et al.
British Journal of Pharmacology
|
November 23, 2012
Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes
A O Watts, M M H van Lipzig, W C Jaeger, et al.
Plos Medicine
|
December 21, 2016
IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study
Yunlei Li, Jessica G C A M Buijs-Gladdines, Kirsten Canté-Barrett, et al.
Frontiers in Oncology
|
August 26, 2024
Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination
Elisa Zanini, Nicole Forster-Gross, Felix Bachmann, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
Nature Communications
|
February 26, 2022
Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategies
Valentina Cordo', Mariska T Meijer, Rico Hagelaar, et al.
Molecular Cancer Therapeutics
|
November 2, 2018
Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017
Joost C M Uitdehaag, Jeffrey J Kooijman, Jeroen A D M de Roos, et al.
Oncotarget
|
April 19, 2017
Stable aneuploid tumors cells are more sensitive to TTK inhibition than chromosomally unstable cell lines
Marion A A Libouban, Jeroen A D M de Roos, Joost C M Uitdehaag, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 5, 2009
Nonpeptidergic allosteric antagonists differentially bind to the CXCR2 chemokine receptor
Petra de Kruijf, Jane van Heteren, Herman D Lim, et al.
Journal of Molecular Biology
|
May 26, 2017
Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity
Joost C M Uitdehaag, Jos de Man, Nicole Willemsen-Seegers, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 5, 2005
Psychiatry in Europe
M Agius, R Zaman, S Singh, et al.
Molecular Cancer Therapeutics
|
September 3, 2016
Cell Panel Profiling Reveals Conserved Therapeutic Clusters and Differentiates the Mechanism of Action of Different PI3K/mTOR, Aurora Kinase and EZH2 Inhibitors
Joost C M Uitdehaag, Jeroen A D M de Roos, Martine B W Prinsen, et al.
British Journal of Pharmacology
|
November 23, 2012
Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes
A O Watts, M M H van Lipzig, W C Jaeger, et al.
Plos Medicine
|
December 21, 2016
IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study
Yunlei Li, Jessica G C A M Buijs-Gladdines, Kirsten Canté-Barrett, et al.
Frontiers in Oncology
|
August 26, 2024
Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination
Elisa Zanini, Nicole Forster-Gross, Felix Bachmann, et al.
Page
of 12